192 related articles for article (PubMed ID: 6373102)
21. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
23. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.
Braude D; Soliz T; Crandall C; Hendey G; Andrews J; Weichenthal L
Am J Emerg Med; 2006 Mar; 24(2):177-82. PubMed ID: 16490647
[TBL] [Abstract][Full Text] [Related]
24. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum.
Jacobs AJ; Deppe G; Cohen CJ
Gynecol Oncol; 1980 Aug; 10(1):55-7. PubMed ID: 7190532
[No Abstract] [Full Text] [Related]
26. [Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
Lehoczky O; Bagaméri A; Sárosi Z; Kulcsár T; Pulay T
Orv Hetil; 2001 Aug; 142(31):1681-4. PubMed ID: 11556262
[TBL] [Abstract][Full Text] [Related]
27. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
28. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
29. Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide.
Neidhart JA; Gagen M; Young D; Wilson HE
Cancer; 1981 Mar; 47(6):1439-43. PubMed ID: 7013968
[TBL] [Abstract][Full Text] [Related]
30. Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy.
Cheirsilpa A; Ratanatharathorn V; Sinlarat P; Chindavijak K; Lousoontornsiri W; Chakrapee-Sirisuk S; Srimuninimit V
J Med Assoc Thai; 1994 Apr; 77(4):201-6. PubMed ID: 7844494
[TBL] [Abstract][Full Text] [Related]
31. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
Plezia PM; Alberts DS; Kessler J; Aapro MS; Graham V; Surwit EA
Cancer Treat Rep; 1984 Dec; 68(12):1493-5. PubMed ID: 6542448
[TBL] [Abstract][Full Text] [Related]
32. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.
Crucitt MA; Hyman W; Grote T; Tester W; Madajewicz S; Yee S; Wentz A; Griffin D; Parasuraman TV; Bryson J
Clin Ther; 1996; 18(3):508-18. PubMed ID: 8829027
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesis.
Roché H; Hyman G; Nahas G; Stoopler M; Ellison R; Desjardins R
Cancer Invest; 1987; 5(2):89-93. PubMed ID: 3607576
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.
Crucitt MA; Hyman W; Grote T; Tester W; Madajewicz S; Yee S; Wentz A; Griffin D; Parasuraman TV; Bryson J
Clin Ther; 1996; 18(4):778-88. PubMed ID: 8879903
[TBL] [Abstract][Full Text] [Related]
38. A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.
Bishop JF; Matthews JP; Wolf MM; Oliver IN; Reynolds S; Walpole E; Rischin D; Buchanan L; Tan LG
Eur J Cancer; 1992; 28(1):47-50. PubMed ID: 1567690
[TBL] [Abstract][Full Text] [Related]
39. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
Donovitz GS; O'Quinn AG; Smith ML
Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
[TBL] [Abstract][Full Text] [Related]
40. Epidural administration of droperidol suppresses cisplatin-induced emesis: preliminary findings.
Iwama H; Arai M
Surg Today; 1998; 28(2):231-4. PubMed ID: 9525020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]